Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3976
PUT
Alkermes
ALKS
$8.32B
| $671K | ﹤0.01% |
32,900
+23,500
| +250% | +$467K |
|
|
GOOD
3977
Gladstone Commercial Corp
GOOD
$593M
| $671K | ﹤0.01% |
30,705
+15,085
| +97% | +$342K |
|
3978
nLIGHT
LASR
$4.24B
| $670K | ﹤0.01% |
33,062
+16,771
| +103% | +$289K |
|
3979
CALL
Trinity Industries
TRN
$2.59B
| $670K | ﹤0.01% |
30,265
+16,000
| +112% | +$326K |
|
3980
Clarivate
CLVT
$1.24B
| $668K | ﹤0.01% |
39,744
+38,070
| +2,274% | +$641K |
|
3981
Intellia Therapeutics
NTLA
$1.53B
| $668K | ﹤0.01% |
45,527
+25,989
| +133% | +$362K |
|
3982
Gorman-Rupp
GRC
$2.25B
| $667K | ﹤0.01% |
17,762
+7,906
| +80% | +$288K |
|
|
ENFC
3983
DELISTED
Entegra Financial Corp.
ENFC
| $667K | ﹤0.01% |
22,094
+18,701
| +551% | +$562K |
|
|
BGG
3984
DELISTED
Briggs & Stratton Corp.
BGG
| $665K | ﹤0.01% |
99,844
+47,171
| +90% | +$289K |
|
3985
PUT
BorgWarner
BWA
$13.7B
| $664K | ﹤0.01% |
17,381
+1,363
| +9% | +$49.9K |
|
3986
Collegium Pharmaceutical
COLL
$1.16B
| $662K | ﹤0.01% |
32,161
+7,753
| +32% | +$129K |
|
3987
Powell Industries
POWL
$7.59B
| $661K | ﹤0.01% |
40,500
+10,830
| +37% | +$152K |
|
|
PFC
3988
DELISTED
Premier Financial Corp. Common Stock
PFC
| $661K | ﹤0.01% |
20,953
+10,968
| +110% | +$331K |
|
3989
UroGen Pharma
URGN
$2.26B
| $660K | ﹤0.01% |
19,753
+9,799
| +98% | +$267K |
|
3990
QCR Holdings
QCRH
$1.72B
| $659K | ﹤0.01% |
15,035
+7,470
| +99% | +$305K |
|
3991
Enovis
ENOV
$1.74B
| $658K | ﹤0.01% |
10,508
-27,628
| -72% | -$1.56M |
|
|
DLA
3992
DELISTED
Delta Apparel Inc.
DLA
| $655K | ﹤0.01% |
21,050
+3,144
| +18% | +$84.2K |
|
|
VSTO
3993
DELISTED
Vista Outdoor Inc.
VSTO
| $655K | ﹤0.01% |
87,712
+26,728
| +44% | +$201K |
|
3994
PUT
Invesco CurrencyShares Australian Dollar Trust
FXA
$97.8M
| $653K | ﹤0.01% |
9,300
+4,500
| +94% | +$308K |
|
3995
PUT
Plains All American Pipeline
PAA
$16.3B
| $653K | ﹤0.01% |
35,500
+19,000
| +115% | +$349K |
|
3996
PUT
AerCap
AER
$24.4B
| $652K | ﹤0.01% |
10,600
+10,200
| +2,550% | +$600K |
|
|
AL
3997
DELISTED
Air Lease Corp
AL
| $650K | ﹤0.01% |
13,683
-1,768
| -11% | -$79.4K |
|
3998
Ezcorp Inc
EZPW
$1.83B
| $650K | ﹤0.01% |
95,099
+19,235
| +25% | +$110K |
|
3999
CALL
Rambus
RMBS
$10.6B
| $650K | ﹤0.01% |
47,200
-26,500
| -36% | -$356K |
|
|
MOBL
4000
DELISTED
MobileIron, Inc.
MOBL
| $649K | ﹤0.01% |
133,417
-175,044
| -57% | -$933K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.